{"id":168673,"date":"2024-03-10T03:13:15","date_gmt":"2024-03-10T07:13:15","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/pharmala-announces-voting-results-of-annual-general-and-special-meeting-of-shareholders-and-provides-corporate-update\/"},"modified":"2024-08-18T11:47:46","modified_gmt":"2024-08-18T15:47:46","slug":"pharmala-announces-voting-results-of-annual-general-and-special-meeting-of-shareholders-and-provides-corporate-update","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/pharmala-announces-voting-results-of-annual-general-and-special-meeting-of-shareholders-and-provides-corporate-update.php","title":{"rendered":"PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update"},"content":{"rendered":"<p><![CDATA[VANCOUVER, British Columbia, March  08, 2024  (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (\u201cPharmAla\u201d or the \u201cCompany\u201d) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo\u2122 MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to provide the following corporate updates.]]><\/p>\n<p>See the original post here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/03\/08\/2843326\/0\/en\/PharmAla-Announces-Voting-Results-of-Annual-General-and-Special-Meeting-of-Shareholders-and-Provides-Corporate-Update.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update\">PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post here: PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/pharmala-announces-voting-results-of-annual-general-and-special-meeting-of-shareholders-and-provides-corporate-update.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-168673","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168673"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=168673"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/168673\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=168673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=168673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=168673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}